Wow_老虎社区_美港股上老虎

jt1994

2021-04-05

Wow

9 Beaten-Down Stocks That Look Promising<blockquote>9只看起来很有前途的遭受重创的股票</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":349202744,"tweetId":"349202744","gmtCreate":1617612602788,"gmtModify":1634297594885,"author":{"id":3580396500800332,"idStr":"3580396500800332","authorId":3580396500800332,"authorIdStr":"3580396500800332","name":"jt1994","avatar":"https://static.tigerbbs.com/256e9b9c026559d0a27973154fbb345d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>Wow</body></html>","htmlText":"<html><head></head><body>Wow</body></html>","text":"Wow","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/349202744","repostId":1186754751,"repostType":4,"repost":{"id":"1186754751","kind":"news","pubTimestamp":1617611806,"share":"https://www.laohunote.com/m/news/1186754751?lang=zh_CN&edition=full","pubTime":"2021-04-05 16:36","market":"us","language":"en","title":"9 Beaten-Down Stocks That Look Promising<blockquote>9只看起来很有前途的遭受重创的股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1186754751","media":"Barrons","summary":"The S&P 500 closed at a record on Thursday, soaring above 4000 for the first time. But not every sto","content":"The S&amp;P 500 closed at a record on Thursday, soaring above 4000 for the first time. But not every stock has shared in those gains so far this year.<blockquote>标普500周四收盘创下历史新高，首次飙升至4000点以上。但今年迄今为止，并非所有股票都分享了这些涨幅。</blockquote>While the majority of S&amp;P 500 stocks are positive for the year, about one in five have declined in the first quarter of 2021. Some are down for fundamental reasons, while others seem to be suffering from the market’s momentum shift from growth stocks to cyclical and value names.<blockquote>虽然大多数标普500股票今年都是积极的，但大约五分之一的股票在2021年第一季度下跌。有些股票因基本面原因下跌，而另一些则似乎受到了市场从成长型股票向周期性股票和价值型股票转变的影响。</blockquote>Once the headwind wanes, however, names that have been left behind are likely to catch up as their earnings estimates remain strong. In some cases, analysts have adjusted their expectations higher this year. That presents a good opportunity to snap up shares of fundamentally solid companies at discount prices.<blockquote>然而，一旦逆风减弱，那些被抛在后面的公司可能会迎头赶上，因为他们的盈利预期仍然强劲。在某些情况下，分析师今年已经上调了预期。这为以折扣价snap基本面稳健公司股票提供了一个好机会。</blockquote>Among the nearly 100 S&amp;P 500 companies whose shares are in negative territory year to date, about half are expected to post 2021 earnings per share that are at least 20% higher than fiscal 2019 earnings. Among those, about 30 are expected to see that strength sustain into 2022, meaning their 2022 earnings are expected to grow at least another 10% from 2021 levels.<blockquote>在今年迄今为止股价处于负值区域的近 100 家标普500公司中，约有一半公司预计 2021 年每股收益将比 2019 财年收益至少高出 20%。其中，约有 30 家公司预计这种实力将持续到 2022 年，这意味着它们 2022 年的盈利预计将比 2021 年的水平再增长至少 10%。</blockquote>To find stocks whose earnings potential may not be reflected in share prices,Barron’stook those 30 names and removed any stocks that traded at more than 30 times 2021 earnings estimates. That left us with nine names.<blockquote>寻找盈利潜力可能无法反映在股价中的股票，巴伦选取这 30 只股票，并删除任何交易价格超过 2021 年收益预期 30 倍的股票。这给我们留下了九个名字。</blockquote>Even better, analysts have raised their 2021 and 2022 earnings estimates for all of the stocks since the end of last year, meaning Wall Street is turning more bullish on them. These discounted names are mostly growth stocks across healthcare, tech, telecommunication, and consumer sectors.<blockquote>更好的是，自去年年底以来，分析师上调了所有股票 2021 年和 2022 年的盈利预期，这意味着华尔街越来越看好它们。这些折扣股票大多是医疗保健、科技、电信和消费行业的成长型股票。</blockquote>Left Behind<blockquote>留下</blockquote>These fundamentally solid stocks are in negative territory for 2021 but look well-positioned to catch up.<blockquote>这些基本面稳健的股票在 2021 年处于负值区域，但看起来有能力迎头赶上。</blockquote><img src=\"https://static.tigerbbs.com/354b69e346e0d3878e95ee2a83301ccf\" tg-width=\"939\" tg-height=\"781\" referrerpolicy=\"no-referrer\"><blockquote></blockquote>Chip maker&nbsp;Qualcomm(ticker: QCOM), for example, has seen its stock tumble nearly 10% year to date. Investors appear unimpressed by the company’s first-quarter revenue, which was 62% higher than a year ago but&nbsp;still missed analysts’ expectations. In the longer term, the company–known for chips that power smartphone processors–could&nbsp;benefit from the world’s transition to 5G networksand the Biden administration’s proposed infrastructure spending.<blockquote>例如，芯片制造商高通（股票代码：QCOM）的股价今年迄今已下跌近 10%。投资者似乎对该公司第一季度的营收不以为然，第一季度的营收比去年同期增长了 62%，但仍低于分析师的预期。从长远来看，这家以智能手机处理器芯片而闻名的公司可能会从全球向 5G 网络的过渡和拜登政府拟议的基础设施支出中受益。</blockquote>Vertex Pharmaceuticals&nbsp;(VTRX) shares are another example where a recent pullback due to negative events may have gone too far. In mid-October, the biotech company canceled the development of a once-promising drug after trial results disappointed. Its stock has plunged 23% since and is down 10% year to date. Despite the flop of that one drug,Barron’s&nbsp;wrote in March that&nbsp;Vertex remains a powerhouse in cystic fibrosis treatment&nbsp;and is developing a promising pipeline beyond that.<blockquote>Vertex Pharmaceuticals (VTRX) 股票是另一个例子，最近因负面事件而导致的回调可能走得太远了。10月中旬，这家生物技术公司在试验结果令人失望后取消了一种曾经很有前途的药物的开发。此后，其股价已暴跌 23%，今年迄今已下跌 10%。尽管那一种药失败了，巴伦三月份写道，Vertex 仍然是囊性纤维化治疗领域的巨头，并且正在开发一条有前途的管道。</blockquote>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>9 Beaten-Down Stocks That Look Promising<blockquote>9只看起来很有前途的遭受重创的股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n9 Beaten-Down Stocks That Look Promising<blockquote>9只看起来很有前途的遭受重创的股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarrons2021-04-05 16:36\n\n</h4>\n</header>\n<article>\nThe S&amp;P 500 closed at a record on Thursday, soaring above 4000 for the first time. But not every stock has shared in those gains so far this year.<blockquote>标普500周四收盘创下历史新高，首次飙升至4000点以上。但今年迄今为止，并非所有股票都分享了这些涨幅。</blockquote>While the majority of S&amp;P 500 stocks are positive for the year, about one in five have declined in the first quarter of 2021. Some are down for fundamental reasons, while others seem to be suffering from the market’s momentum shift from growth stocks to cyclical and value names.<blockquote>虽然大多数标普500股票今年都是积极的，但大约五分之一的股票在2021年第一季度下跌。有些股票因基本面原因下跌，而另一些则似乎受到了市场从成长型股票向周期性股票和价值型股票转变的影响。</blockquote>Once the headwind wanes, however, names that have been left behind are likely to catch up as their earnings estimates remain strong. In some cases, analysts have adjusted their expectations higher this year. That presents a good opportunity to snap up shares of fundamentally solid companies at discount prices.<blockquote>然而，一旦逆风减弱，那些被抛在后面的公司可能会迎头赶上，因为他们的盈利预期仍然强劲。在某些情况下，分析师今年已经上调了预期。这为以折扣价snap基本面稳健公司股票提供了一个好机会。</blockquote>Among the nearly 100 S&amp;P 500 companies whose shares are in negative territory year to date, about half are expected to post 2021 earnings per share that are at least 20% higher than fiscal 2019 earnings. Among those, about 30 are expected to see that strength sustain into 2022, meaning their 2022 earnings are expected to grow at least another 10% from 2021 levels.<blockquote>在今年迄今为止股价处于负值区域的近 100 家标普500公司中，约有一半公司预计 2021 年每股收益将比 2019 财年收益至少高出 20%。其中，约有 30 家公司预计这种实力将持续到 2022 年，这意味着它们 2022 年的盈利预计将比 2021 年的水平再增长至少 10%。</blockquote>To find stocks whose earnings potential may not be reflected in share prices,Barron’stook those 30 names and removed any stocks that traded at more than 30 times 2021 earnings estimates. That left us with nine names.<blockquote>寻找盈利潜力可能无法反映在股价中的股票，巴伦选取这 30 只股票，并删除任何交易价格超过 2021 年收益预期 30 倍的股票。这给我们留下了九个名字。</blockquote>Even better, analysts have raised their 2021 and 2022 earnings estimates for all of the stocks since the end of last year, meaning Wall Street is turning more bullish on them. These discounted names are mostly growth stocks across healthcare, tech, telecommunication, and consumer sectors.<blockquote>更好的是，自去年年底以来，分析师上调了所有股票 2021 年和 2022 年的盈利预期，这意味着华尔街越来越看好它们。这些折扣股票大多是医疗保健、科技、电信和消费行业的成长型股票。</blockquote>Left Behind<blockquote>留下</blockquote>These fundamentally solid stocks are in negative territory for 2021 but look well-positioned to catch up.<blockquote>这些基本面稳健的股票在 2021 年处于负值区域，但看起来有能力迎头赶上。</blockquote><img src=\"https://static.tigerbbs.com/354b69e346e0d3878e95ee2a83301ccf\" tg-width=\"939\" tg-height=\"781\" referrerpolicy=\"no-referrer\"><blockquote></blockquote>Chip maker&nbsp;Qualcomm(ticker: QCOM), for example, has seen its stock tumble nearly 10% year to date. Investors appear unimpressed by the company’s first-quarter revenue, which was 62% higher than a year ago but&nbsp;still missed analysts’ expectations. In the longer term, the company–known for chips that power smartphone processors–could&nbsp;benefit from the world’s transition to 5G networksand the Biden administration’s proposed infrastructure spending.<blockquote>例如，芯片制造商高通（股票代码：QCOM）的股价今年迄今已下跌近 10%。投资者似乎对该公司第一季度的营收不以为然，第一季度的营收比去年同期增长了 62%，但仍低于分析师的预期。从长远来看，这家以智能手机处理器芯片而闻名的公司可能会从全球向 5G 网络的过渡和拜登政府拟议的基础设施支出中受益。</blockquote>Vertex Pharmaceuticals&nbsp;(VTRX) shares are another example where a recent pullback due to negative events may have gone too far. In mid-October, the biotech company canceled the development of a once-promising drug after trial results disappointed. Its stock has plunged 23% since and is down 10% year to date. Despite the flop of that one drug,Barron’s&nbsp;wrote in March that&nbsp;Vertex remains a powerhouse in cystic fibrosis treatment&nbsp;and is developing a promising pipeline beyond that.<blockquote>Vertex Pharmaceuticals (VTRX) 股票是另一个例子，最近因负面事件而导致的回调可能走得太远了。10月中旬，这家生物技术公司在试验结果令人失望后取消了一种曾经很有前途的药物的开发。此后，其股价已暴跌 23%，今年迄今已下跌 10%。尽管那一种药失败了，巴伦三月份写道，Vertex 仍然是囊性纤维化治疗领域的巨头，并且正在开发一条有前途的管道。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.barrons.com/articles/9-beaten-down-stocks-that-look-promising-51617404656?mod=RTA\">Barrons</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARTX":"阿罗特克","CHTR":"特许通讯","DPZ":"达美乐比萨","LDOS":"Leidos Holdings Inc","GPN":"环汇有限公司","DVA":"达维塔保健","QCOM":"高通"},"source_url":"https://www.barrons.com/articles/9-beaten-down-stocks-that-look-promising-51617404656?mod=RTA","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186754751","content_text":"The S&P 500 closed at a record on Thursday, soaring above 4000 for the first time. But not every stock has shared in those gains so far this year.While the majority of S&P 500 stocks are positive for the year, about one in five have declined in the first quarter of 2021. Some are down for fundamental reasons, while others seem to be suffering from the market’s momentum shift from growth stocks to cyclical and value names.Once the headwind wanes, however, names that have been left behind are likely to catch up as their earnings estimates remain strong. In some cases, analysts have adjusted their expectations higher this year. That presents a good opportunity to snap up shares of fundamentally solid companies at discount prices.Among the nearly 100 S&P 500 companies whose shares are in negative territory year to date, about half are expected to post 2021 earnings per share that are at least 20% higher than fiscal 2019 earnings. Among those, about 30 are expected to see that strength sustain into 2022, meaning their 2022 earnings are expected to grow at least another 10% from 2021 levels.To find stocks whose earnings potential may not be reflected in share prices,Barron’stook those 30 names and removed any stocks that traded at more than 30 times 2021 earnings estimates. That left us with nine names.Even better, analysts have raised their 2021 and 2022 earnings estimates for all of the stocks since the end of last year, meaning Wall Street is turning more bullish on them. These discounted names are mostly growth stocks across healthcare, tech, telecommunication, and consumer sectors.Left BehindThese fundamentally solid stocks are in negative territory for 2021 but look well-positioned to catch up.Chip maker Qualcomm(ticker: QCOM), for example, has seen its stock tumble nearly 10% year to date. Investors appear unimpressed by the company’s first-quarter revenue, which was 62% higher than a year ago but still missed analysts’ expectations. In the longer term, the company–known for chips that power smartphone processors–could benefit from the world’s transition to 5G networksand the Biden administration’s proposed infrastructure spending.Vertex Pharmaceuticals (VTRX) shares are another example where a recent pullback due to negative events may have gone too far. In mid-October, the biotech company canceled the development of a once-promising drug after trial results disappointed. Its stock has plunged 23% since and is down 10% year to date. Despite the flop of that one drug,Barron’s wrote in March that Vertex remains a powerhouse in cystic fibrosis treatment and is developing a promising pipeline beyond that.","news_type":1,"symbols_score_info":{"GPN":0.9,"LDOS":0.9,"ALXN":0.9,"BLL":0.9,"DVA":0.9,"CHTR":0.9,"DPZ":0.9,"ARTX":0.9,"QCOM":0.9}},"isVote":1,"tweetType":1,"viewCount":670,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/349202744"}